What Diseases Disproportionately Affect Black People?

Health disparities represent preventable differences in the burden of disease, injury, or opportunities to achieve optimal health, systematically experienced by socially disadvantaged populations. These differences are not primarily rooted in inherent biology but rather in the social, economic, and environmental conditions where people live, work, and age. Understanding the disproportionate impact of certain conditions requires separating the few diseases with a clear genetic link from the majority of chronic illnesses driven by systemic inequities. This distinction is necessary to accurately frame health inequity and target effective interventions.

Health Conditions with Genetic Predisposition

A small number of health conditions are disproportionately prevalent in Black populations due to inherited genetic traits. Sickle Cell Disease (SCD) is the most recognized example, caused by an alteration in the hemoglobin gene that makes red blood cells rigid and sticky. In the United States, approximately one in every 365 Black newborns is born with SCD. The sickle cell trait (SCT), carried by about one in 13 Black babies, offers protection against severe malaria, which historically drove the high prevalence of this gene variant.

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is an X-linked genetic condition affecting red blood cell stability, prevalent in about one in ten African American males. This enzyme deficiency causes the premature breakdown of red blood cells, resulting in hemolytic anemia, often triggered by certain medications or infections. The G6PD trait also indirectly impacts the diagnosis of Type 2 Diabetes. Because G6PD-deficient individuals have a shortened red blood cell lifespan, their hemoglobin A1c (HbA1c) test results are artificially lowered. This effect can lead to a delayed diagnosis of Type 2 Diabetes by over four years, increasing the risk of severe complications.

Disparities in Chronic Disease Prevalence

Most health conditions disproportionately affecting Black populations are chronic diseases where incidence, onset, or outcomes are significantly worse, rather than primarily genetic. Hypertension is particularly prevalent, affecting 54% of Black men and 61% of Black women aged 20 and older. These rates are substantially higher than those seen in non-Hispanic white adults, and onset often occurs earlier in life.

Type 2 Diabetes presents a major health gap, with Black adults diagnosed 24% more frequently than the general population. This elevated incidence translates to worse outcomes, including a 40% higher death rate from diabetes and a 2.19 times higher rate of end-stage renal disease. Black populations also experience higher mortality rates for most cancers and shorter survival times. For example, Black men are 73% more likely to develop prostate cancer and twice as likely to die from it than white men.

A stark disparity exists in maternal health outcomes, where Black people are nearly three times more likely to die due to pregnancy-related reasons compared to white people (39.9 versus 14.1 per 100,000 live births). This gap is paralleled by infant mortality rates, which are more than double for Black infants (10.6 per 1,000 live births) compared to white infants (4.4 per 1,000 live births). These realities highlight a pervasive pattern of unequal health outcomes across the lifespan.

Understanding the Social Determinants of Health

The majority of health disparities in chronic disease are driven by the Social Determinants of Health (SDOH), which are the non-medical factors influencing health outcomes. These determinants include:

  • Economic Stability
  • Neighborhood and Built Environment
  • Education Access and Quality
  • Healthcare Access and Quality
  • Social and Community Context

The lasting effects of historical policies like residential segregation and redlining concentrate Black populations in neighborhoods with fewer health-supporting resources.

These areas often feature limited access to healthy food, higher rates of environmental pollution, and fewer safe places for physical activity, directly contributing to chronic disease risk factors. Economic instability and lower education quality restrict opportunities for stable employment and health insurance, creating financial barriers to preventative care. When individuals seek care, they may encounter provider bias or a lack of cultural competency, leading to poorer quality of care and mistrust of the medical system.

The chronic experience of racism and discrimination acts as a constant, unpredictable stressor with a direct physiological impact. This phenomenon is known as allostatic load, the cumulative “wear and tear” on the body from chronic stress. Prolonged exposure activates the body’s fight-or-flight response, leading to chronic inflammation and increased stress hormones. This biological burden raises the risk for hypertension, diabetes, and heart disease, accelerating biological aging and contributing to the earlier onset of these conditions.

Improving Outcomes and Promoting Health Equity

Improving health outcomes requires focused, systemic changes that address the root causes within the social determinants of health. Policy interventions aimed at improving economic stability, education quality, and housing security are fundamental steps toward creating healthier environments. Advocating for policies that address food deserts and ensuring access to affordable, stable housing can directly mitigate environmental risk factors for chronic disease.

Within the healthcare system, improving access to preventative care and addressing insurance-based barriers is necessary, such as designing coverage that promotes better maternal health outcomes. Efforts to increase the diversity of the healthcare workforce and implement implicit bias training for providers foster a more trusting and culturally competent care environment. Community-based health programs are also effective, incorporating community leadership and meeting people where they are. Furthermore, utilizing data systems that track and stratify clinical outcomes by race and ethnicity is necessary to identify equity gaps and measure the effectiveness of corrective strategies.